Consumer groups urge Congress not to rush FDA rulemaking on CBD

A few health and consumer advocacy organizations are urging Congress “to reject any attempts to force federal regulators” to legalize CBD immediately. In a June 17 letter to Congress members, the organizations say Congress itself “is not the right evaluator of the safety of consumer products” because representatives and senators can be influenced by “well-funded […]

Consumer groups urge Congress not to rush FDA rulemaking on CBD is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs